The Recall Desk
SevereFDA (Drugs)·D-0407-2019·Announced 2019-01-09

Northwest Compounding Pharmacy Recalls Glutathione Liquid Due to Sterility Concerns

Northwest Compounding Pharmacy is recalling prescription Glutathione liquid in Oregon due to a lack of sterility assurance.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant injury/property-damage reports or hospitalization are rated Severe. Lack of sterility assurance in a compounded injectable/liquid product presents a significant risk of serious injury.

Plain-English summary

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy is recalling prescription Glutathione liquid, 200mg/ml. The recall was initiated because the product lacks sterility assurance.

The affected product was distributed exclusively in the state of Oregon. Distribution included 3 medical facilities, 1 physician's office, and 80 consumers or patients. As these are compounded products, labels vary for each compound and are specific to each patient. The firm did not provide specific labeling details.

Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
Glutathione liquid, 200mg/ml, Rx

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • 10092018@5

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 17 recalled by Hiers Enterprises, LLC dba Northwest Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 17 products in this recall →